( en | de | ru )

 

Disambiguation of "Buyse, Marc"

Author of the publication

copydeleteadd this publication to your clipboard
Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward.

, , , , , and . Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 20 (3): 487-495 (March 2017)Mesures de resultats; Surrogate endpoints.
DOI: 10.1016/j.jval.2016.10.011

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Stefanie Marczoch

Langzeitverlauf von 200 Patienten mit kraniofazialen und zervikalen Dystonien bis zu 12 Jahre nach der ersten Botulinumtoxin-Behandlung. TU München, (2009)

Hans-Peter Marchal

Erna Marcus

Friedrich Marcus

Paul March

 

Other publications of authors with the same name

Statistical evaluation of surrogate endpoints with examples from cancer clinical trials., , , , , , and . Biometrical journal. Biometrische Zeitschrift, 58 (1): 104-32 (January 2016)Mesures de resultats; Surrogate endpoints; Oncologia; Online.Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema., , , , , , , , , and 11 other author(s). The Journal of rheumatology, 34 (3): 607-15 (March 2007)Mesures de resultats; Surrogate endpoints.On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints., , , , and . Biometrics, 71 (1): 15-24 (2015)Mesures de resultats; Surrogate endpoints; Validació.Reformulating the hazard ratio to enhance communication with clinical investigators.. Clinical trials (London, England), 5 (6): 641-2 (January 2008)4679<m:linebreak></m:linebreak>JID: 101197451; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials, , , , , and . Journal of Statistical Planning and Inference, 138 (2): 432--449 (Feb 1, 2008)Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials., , , , , and . Comput. Stat. Data Anal., 55 (9): 2748-2757 (2011)Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward., , , , , and . Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 20 (3): 487-495 (March 2017)Mesures de resultats; Surrogate endpoints.